Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 169 (RNA5SP169) is a genomic DNA sequence annotated as a pseudogene resembling the 5S ribosomal RNA gene family. Pseudogenes are genetic elements similar to genes but contain disabling mutations that prevent them from encoding functional RNA or proteins[2][6]. rRNA pseudogenes such as RNA5SP169 are not translated or expressed as functional ribosomal RNA. The 5S rRNA is normally an essential part of the ribosomal large subunit involved in protein synthesis, but pseudogenes like RNA5SP169 are non-functional relics arising through gene duplication or retrotransposition events[1][2][6]. Their presence in the genome can serve as evolutionary footprints and, in rare cases, these RNAs might get transcribed, but evidence for functional regulatory or pathogenic roles for this specific pseudogene is lacking. RNA5SP169 is not a classical therapeutic target, receptor, or enzyme, and is generally excluded from pharmaceutical targeting databases[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 169 (RNA5SP169).